Every eighth child is projected to have a mental health condition. A number of predictors of children’s mental health problems have been identified, although much remains unknown. Previous study reveals that low vitamin D levels in children may be one factor contributing to an increased risk of mental health disorders later in life. A recent Finnish study, currently published in JAMA Network Open, adds to the body of knowledge about the relationship between vitamin D intake and mental health.
A recent study by a group of Finnish researchers looked into whether taking a daily vitamin D3 supplement at a higher level than the recommended dose in early childhood lessens the risk of psychiatric symptoms later in life.
The research is part of the Vitamin D Intervention in Infants (VIDI) clinical trial, which is looking into how early vitamin D3 supplementation affects children’s growth and development. The children in the study were divided into two groups, one receiving the daily standard dose of 10 micrograms and the other receiving treble the amount—30 g—of vitamin D. From the age of two weeks to two years, the children got the supplements on a daily basis.
The children were followed up on, and the most recent monitoring point occurred when they were between the ages of six and eight. In the most recent follow-up phase, the parents of 346 children completed a questionnaire to assess their child’s psychiatric symptoms.
The study discovered that taking more vitamin D3 than the recommended daily dose lowered the chance of internalizing difficulties in children. In other words, children who received the greater dose reported less low mood, anxiety, and withdrawn behavior from their parents than children who received the usual amount.
Parents’ Reports of Psychiatric Symptoms
According to the study findings, 11.8% of children who got the normal amount of daily vitamin D supplement of 10 g till the age of two years exhibited clinically significant internalizing issues. 5.6% of the youngsters who received the triple vitamin D supplement had comparable issues.
“Our results suggest that a higher dose of vitamin D3 supplementation during the first years of life may reduce the risk of internalizing psychiatric symptoms in late preschool and early school age,” says Samuel Sandboge, Postdoctoral Research Fellow at Tampere University.
“The results and their potential implications are interesting, but further research is needed to confirm the results. In the interpretation of the results, we must note, among other things, that we studied the psychiatric symptoms only as parent-reported. Furthermore, the participants of the study were children with Nordic ancestry living in Finland who had good levels of vitamin D,” Sandboge says.
The researchers found no differences in externalizing problems like aggression and rule breaking. Furthermore, no variations in the overall severity of psychiatric symptoms were discovered in the youngsters.
more recommended stories
Psychedelic Use Linked to Major Life Changes StudyQuick Summary 83% of users reported.
Nutrition Research: Why Context Matters for Healthy FoodsQuick Summary Foods do not have.
Hyperemesis Gravidarum Genes: Largest GWAS StudyQuick Summary Largest GWAS identifies 10.
Brain Categorization Redefined by New Neuroscience StudyKey Highlights Brain Categorization is not.
GLP-1 Drug Effectiveness Reduced by Genetic VariantsKey Points Summary Genetic variants in.
TB Vaccines Show Safety but Limited Protection in Large TrialKey Highlights Two candidate Tuberculosis vaccines,.
Drug Overdose Spike 2025 Was a Modeling ErrorQuick Summary A reported U.S. drug.
One Health Summit: WHO Leads Global Health ResponseKey Highlights Global leaders convened in.
Prenatal Smoking Raises Risk of Child Mental DisordersKey Summary Prenatal smoking is associated.
Stroke Risk Linked to Low Birthweight, Not Adult BMIKey Points Low birthweight is associated.

Leave a Comment